MICURAE‘s latest news.
Theranostics unit at GenesisCare offers new therapy for prostate cancer
Theranostics is a personalised approach to treating cancer, using both diagnosis and therapy tools as part of the treatment. Theranostics uses PET scan imaging (a special type of scan) to see if specific targets, known…Read More
Micurae’s partner-Circle Harmony is partnering with HCA Healthcare UK
HCA Healthcare UK is partnering with Circle Harmony to provide international patients, based in China, access to oncology expertise and treatment by HCA UK. Reflecting how advances in technology are creating new ways to provide…Read More
Micurae Collaborating with Beijing Heal Star Clinic – A Bespoke Family Clinic under Shanghai Fosun Pharmaceuticals.
Founded in 1994 and listed on the Shanghai Stock Exchange in August 1998, Shanghai Fosun Pharmaceuticals (Group) Co., Ltd. ("Fosun Pharma") is China's leading healthcare industry group. Fosun Pharmaceutical Group to promote human health as…Read More
Micurae Collaborating with Penguin Almond Clinic (Xi’an)
From April 13, 2020, the Penguin Almond Group Xi'an Surgery Center will also become the eighth day surgical centre of the Penguin Almond Group (Tencent) after Shenyang, Shenzhen, Chengdu, Guangzhou, Shanghai, Nanjing. The day surgical…Read More
The Import Expo, Shanghai, China 2019
Micurae, as a leading Australian Medical Consultative Company, was invited to present our cloud based international second opinion platform and end-to-end Tele-health capabilities. It was a fantastic opportunity to showcase our products and services to…Read More